N-(3-(7-((6-(4-hydroxypiperidin-1-yl)pyridin-3-yl)amino)-1-methyl-1,4-dihydropyrimido[4,5-d]pyrimidin-3(2H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide | 2031152-10-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(3-(7-((6-(4-hydroxypiperidin-1-yl)pyridin-3-yl)amino)-1-methyl-1,4-dihydropyrimido[4,5-d]pyrimidin-3(2H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide
• 英文别名: XMU-MP-2；N-[3-[2-[[6-(4-hydroxypiperidin-1-yl)pyridin-3-yl]amino]-8-methyl-5,7-dihydropyrimido[4,5-d]pyrimidin-6-yl]-4-methylphenyl]-3-(trifluoromethyl)benzamide
• CAS: 2031152-10-8
• 化学式: C₃₂H₃₃F₃N₈O₂
• 分子量: 618.662
• InChiKey: ZGTWRRCZLAOQMY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  45
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  110
• 氢给体数：
  3
• 氢受体数：
  12

文献信息

• [EN] PREPARATION AND USE OF NOVEL PROTEIN KINASE INHIBITORS<br/>[FR] PRÉPARATION ET UTILISATION DE NOUVEAUX INHIBITEURS DE PROTÉINE KINASE
  申请人：RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

  公开号：WO2016168992A1

  公开（公告）日：2016-10-27

  The invention provides novel compounds and methods of using such compounds to treat or prevent cancer.

  这项发明提供了新型化合物以及使用这些化合物来治疗或预防癌症的方法。
• Preparation and use of novel protein kinase inhibitors
  申请人：Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

  公开号：US10364247B2

  公开（公告）日：2019-07-30

  The invention provides novel compounds and methods of using such compounds to treat or prevent cancer.

  本发明提供了新型化合物和使用此类化合物治疗或预防癌症的方法。
• PREPARATION AND USE OF NOVEL PROTEIN KINASE INHIBITORS
  申请人：Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

  公开号：US20180105528A1

  公开（公告）日：2018-04-19

  The invention provides novel compounds and methods of using such compounds to treat or prevent cancer.